Skip to main content Skip to footer

Press Releases

Bringing Science to Society™

Investors

Investors

  • Overview
  • Press Releases
  • Investor Events
  • Presentations
  • Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • Stock Information
    • Quote
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
May 04, 2022 4:05pm EDT

Societal CDMO to Report Financial Results for First Quarter 2022 on May 11, 2022

Apr 27, 2022 7:00am EDT

Societal CDMO Secures Manufacturing and Packaging Task Order Award from National Cancer Institute (NCI)

Apr 06, 2022 4:05pm EDT

Societal CDMO Reports Inducement Grants for New Staff

Mar 21, 2022 7:00am EDT

Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformation

Mar 01, 2022 4:05pm EST

Recro Reports Fourth Quarter and Year End 2021 Financial Results

Feb 23, 2022 7:00am EST

Recro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego Facility

Feb 22, 2022 4:05pm EST

Recro to Report Financial Results for Fourth Quarter and Year-end 2021 on March 1, 2022

Jan 26, 2022 7:00am EST

Recro Wins $1.5 Million Formulation Development and CGMP Manufacturing Contract to Support Clinical Development of Topical Treatment for Skin Cancer Prevention

Jan 19, 2022 7:00am EST

Recro Appoints Eduardo Uribe as Head of Quality for Recro San Diego

Jan 06, 2022 4:05pm EST

Recro Reports Inducement Grants For New Staff

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 24
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Copyright ©2023 Societal CDMO. All rights reserved. Manage Cookie Preferences
Follow us